News & Updates

Closed-loop trumps sensor-augmented pumps for older T1D patients
Closed-loop trumps sensor-augmented pumps for older T1D patients
04 Jan 2022 byTristan Manalac

A closed-loop insulin delivery system is both effective and safe for the management of type 1 diabetes (T1D) in older adults, according to a recent study. As compared with sensor-augmented pump systems, closed-loop deliveries yield greater time-in-range (TIR) outcomes and help minimize time spent in hypoglycaemic range overnight.

Closed-loop trumps sensor-augmented pumps for older T1D patients
04 Jan 2022
Entinostat-exemestane combo yields survival benefit for HR+ advanced BC
Entinostat-exemestane combo yields survival benefit for HR+ advanced BC
04 Jan 2022 byAudrey Abella

In women with hormone-receptor positive advanced breast cancer (HR+ aBC), the addition of the class I selective histone deacetylase (HDAC) inhibitor entinostat to exemestane appeared to be better than treatment with exemestane alone in terms of survival benefit, according to a phase III trial from China.

Entinostat-exemestane combo yields survival benefit for HR+ advanced BC
04 Jan 2022
Breast cancer survivors at greater risk of non-Hodgkin lymphoma
Breast cancer survivors at greater risk of non-Hodgkin lymphoma
03 Jan 2022